Skip to main content

ERRATUM article

Front. Pharmacol., 11 March 2024
Sec. Inflammation Pharmacology
Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1393029

Erratum: PDE9 inhibitor PF-04447943 attenuates DSS-induced colitis by suppressing oxidative stress, inflammation, and regulating T-cell polarization

This article is an erratum on:

  1. PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
PDE9 inhibitor PF-04447943 attenuates DSS-induced colitis by suppressing oxidative stress, inflammation, and regulating T-cell polarization

by Rana MN, Lu J, Xue E, Ruan J, Liu Y, Zhang L, Dhar R, Li Y, Hu Z, Zhou J, Ma W and Tang H (2021). Front. Pharmacol. 12:643215. doi: 10.3389/fphar.2021.643215

Due to a production error, a footnote (†) to the author list was incomplete and was also incorrectly not applied to the author Mohammad Nasiruddin Rana. The correct author list and footnote are as follows:

Mohammad Nasiruddin Rana1†, Jie Lu2†, Enfu Xue1†, Jingjing Ruan1†, Yuting Liu1†, Lejun Zhang1, Rana Dhar1, Yajun Li1, Zhengqiang Hu1, Jie Zhou3, Wangqian Ma4* and Huifang Tang1*

† These authors have contributed equally to this work and share first authorship

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: ulcerative colitis, PF-04447943, inflammasome, Treg/Th17 cell balance, PDE9A, oxidative stress

Citation: Frontiers Production Office (2024) Erratum: PDE9 inhibitor PF-04447943 attenuates DSS-induced colitis by suppressing oxidative stress, inflammation, and regulating T-cell polarization. Front. Pharmacol. 15:1393029. doi: 10.3389/fphar.2024.1393029

Received: 28 February 2024; Accepted: 28 February 2024;
Published: 11 March 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.